NLS Profiles

Teitur Trophics' co-founder and CEO Simon Mølgaard was named Rising Star in Danish Biotech at the DANISH BIO – Dansk Biotek Spring Gala in April 2026. Nordic Life Science asked him about the transition from science to business, building a company from Aarhus, and the opportunities ahead in treating neurodegenerative disease.

After a full career building life science communities and now approaching something akin to retirement – meaning only cherry-picking the projects that appeal to him – French-born Olivier Duchamp-Giudicelli reflects on the accidental advent of NLSDays in 2014, and how partnering and dealmaking have changed over the years.

Thomas Karikari’s career has taken him across three continents: from Ghana to the UK and Sweden, and then to the US. Now an Associate Professor at the University of Pittsburgh and one of Nature Index’s “rising stars in ageing research”, he is helping move Alzheimer’s blood biomarkers beyond individual markers and towards a more complete picture of disease biology.

Spanish biochemist and molecular biologist Salvador Aznar Benitah’s research focuses on how adult stem cells function in normal conditions, aging, and cancer, with particular interest in epigenetics, circadian rhythms, and the mechanisms that allow certain cancer cells to initiate metastasis.

It’s one thing to “do” physics – but it’s another to explain its fundamentals to others, and the role that physics and other sciences play in their lives.

Dr. Joanna Rorbach, principal researcher at the Department of Medical Biochemistry and Biophysics at Karolinska Institutet, has been awarded the prestigious Göran Gustafsson Prize by the Royal Swedish Academy of Sciences (Kungliga Vetenskapsakademien).